ææš
ææš
æ°å€
æ¹åæ§
MACD(12,26,9)
-0.005
売ã
RSI(14)
41.670
äžç«
STOCH(KDJ)(9,3,3)
29.819
äžç«
ATR(14)
0.171
é«å€åç
CCI(14)
-83.775
äžç«
Williams %R
77.778
売ã
TRIX(12,20)
-0.204
売ã
StochRSI(14)
19.447
äžç«
îæ€çŽ¢
îæ€çŽ¢
î
Kamada Ltd
KMDAîãŠã©ãããªã¹ãã«è¿œå
6.940USD
-0.050-0.72%
ååŒæé ïŒETïŒ15åé
ãã®æ ªäŸ¡
400.34Mæ䟡ç·é¡
19.81çŽè¿12ã¶æPER
詳现ãã£ãŒãã衚瀺
TradingKeyãã£ãŒãIntraday
1m
30m
1h
D
W
M
D
æ¬æ¥
-0.72%
5æ¥é
-2.12%
1ã¶æ
-4.41%
6ã¶æ
-21.76%
幎åæ¥
-1.70%
1幎é
-10.10%
äž»èŠããŒã¿
6.910å§å€
6.998é«å€
13.44Kåºæ¥é«
19.81çŽè¿12ã¶æPER
11.20äºæ³PER
0.188çŽè¿12ã¶æé
åœ
0.02%売買å転ç
6.990åæ¥çµå€
6.890å®å€
68.24K売買代é
27.68æ ªäŸ¡åçç
1.54PBRïŒæ ªäŸ¡çŽè³ç£åçïŒ
2.70%çŽè¿12ã¶æé
åœå©åã
5.37%ç·è³ç£å©çç
9.35052é±é«å€
0.43åºæ¥é«æ¯ç%
14.46MçŽå©ç
57.69Mæ ªåŒæ°
0.35041æ ªåœããå©çïŒEPSïŒ
0.87ããŒã¿å€
7.97%èªå·±è³æ¬å©çç
6.50052é±å®å€
1.55%æ¯ãå¹
42.25%ç²å©çç
400.34Mæ䟡ç·é¡
-3.53ãªã¹ã¯ãªã¿ãŒã³
1.42%ãªã¹ã¯ç
TradingKeyã®Kamada Ltdã®æ ªåŒã¹ã³ã¢î
é貚: USD æŽæ°æå»: 2026-07-27äž»èŠã€ã³ãµã€ã
Kamada Ltdã®ãã¡ã³ãã¡ã³ã¿ã«ãºã¯æ¯èŒçå¥å šã§ããæé·ã®å¯èœæ§ã¯é«ãã§ããããªã¥ãšãŒã·ã§ã³ã¯é©æ£äŸ¡æ Œãšè©äŸ¡ãããŠããŸããå»è¬åæ¥çã§ã®é äœã¯155äž80äœã§ããæ©é¢æè³å®¶ä¿æçã¯éåžžã«é«ãã§ããéå»1ãæéã«è€æ°ã®ã¢ããªã¹ããè²·ããšè©äŸ¡ããæé«ç®æšæ ªäŸ¡ã¯13.00ãšãããŠããŸããäžæçã«ã¯ãæ ªäŸ¡ã¯äžéãã¬ã³ããšäºæ³ãããŸããæ ªåŒåžå Žã§ã®ããã©ãŒãã³ã¹ã¯ãã®1ãæã§äœèª¿ã§ããããå瀟ã®ãã¡ã³ãã¡ã³ã¿ã«ãºã¯å 調ã§ããæ ªäŸ¡ã¯æ¯æç·ãšæµæç·ã®éã§æšªã°ãæšç§»ããŠãããã¬ã³ãžçžå Žã§ã®ã¹ã€ã³ã°ãã¬ãŒãã«é©ããŠããŸãã
Kamada Ltdã®ã¹ã³ã¢î°î°
ãµããŒãã©ã€ã³ãšã¬ãžã¹ã¿ã³ã¹ã©ã€ã³
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
ã¬ãŒããŒãã£ãŒã
çŸåš
ååå€
ã¡ãã£ã¢å ±é
éå»24æé
å ±éã¬ãã«
éåžžã«äœã
éåžžã«é«ã
ããžãã£ã+
Kamada Ltdã®æ³šç®ãã€ã³ã
匷ã¿ãªã¹ã¯
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
é«æé·
å瀟ã®åçã¯éå»3幎éã«ãããçå®ã«å¢å ããŠããã幎平åã§26.62%ã®æé·çã瀺ããŠããŸãã
é«ãå©çæé·
å瀟ã®çŽå©çã¯æ¥çããªãŒãããŠãããææ°ã®å¹ŽéçŽå©çã¯USD 180.46Mã§ãã
å²å®
å瀟ã®ææ°ã®PEã¯19.95ã§ãéå»3幎éã®æ°Žæºãšæ¯èŒããŠå®å€åã«ãããŸãã
æ©é¢æè³å®¶ã®å£²ãè¶ã
ææ°ã®æ©é¢æè³å®¶ã®ä¿ææ ªæ°ã¯28.17Mæ ªã§ãåååææ¯ã§7.11%æžå°ããŠããŸãã
ETHSXãä¿æ
ã¹ã¿ãŒæè³å®¶ETHSXã¯æ¬éæã3.03Kæ ªä¿æããŠããŸãã
ã¢ããªã¹ãè©äŸ¡
3
人ã®ã¢ããªã¹ãäºæ³ã«åºã¥ã
è²·ã
çŸåšã®è©äŸ¡
13.000
ç®æšæ ªäŸ¡
+84.14%
äžæäœå°
Kamada Ltd ãã¥ãŒã¹
ææ°æ
å ±ããåŸ
ã¡ãã ãã...
åçäºæž¬î
ã¢ããªã¹ãè©äŸ¡
3
人ã®ã¢ããªã¹ãäºæ³ã«åºã¥ã
è²·ã
çŸåšã®è©äŸ¡
13.000
ç®æšæ ªäŸ¡
+84.14%
äžæäœå°
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
åæ¥ä»ç€Ÿæ¯èŒ
160
åèš
6
äžå€®å€
9
å¹³å
äŒç€Ÿå
è©äŸ¡
ã¢ããªã¹ã
Kamada Ltd
KMDA
3
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
34
Pfizer Inc
PFE
32
AbbVie Inc
ABBV
32
1
2
3
...
32
ææšî
移åå¹³å
ææš
æ°å€
æ¹åæ§
MA5
7.060
売ã
MA10
7.077
売ã
MA20
7.201
売ã
MA50
7.388
売ã
MA100
7.907
売ã
MA200
7.705
売ã
財åææšî
EPS
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
ç·å£²äžé«
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
Kamada Ltdã®äŒæ¥æ å ±î
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
äŒæ¥ã³ãŒãKMDA
äŒæ¥åKamada Ltd
æé«çµå¶è²¬ä»»è
ãCEOãLondon (Amir)
ãŠã§ããµã€ãhttps://www.kamada.com/
æ ªäž»çµ±èšî
é¢é£éèåå
+2.18%
+0.23%
+1.86%
+3.06%
+0.77%
+2.55%
+4.47%
+2.55%
+3.03%
+2.49%
+1.84%
+2.41%
+3.44%
+3.49%
+5.03%
0.00%
+4.43%
+0.56%
+1.52%
-1.83%人æ°éæ
52756.400
+517.400Â (+0.99%)
27768.700
-287.300Â (-1.02%)
7429.500
+11.100Â (+0.15%)
14734.000
-379.000Â (-2.51%)
62393.000
-1412.000Â (-2.21%)
6296.700
-14.600Â (-0.23%)
78.490
-2.847Â (-3.50%)
339.650
+2.740Â (+0.81%)
197.450
+0.940Â (+0.48%)
4022.890
-53.550Â (-1.31%)
ãããã質å
Kamada LtdïŒKMDAïŒã®çŸåšã®æ ªäŸ¡ã¯ãããã§ããïŒ
îKamada LtdïŒKMDAïŒã®çŸåšã®æ ªäŸ¡ã¯6.94ã§ãã
Kamada Ltdã®ãã£ãã«ãŒã·ã³ãã«ã¯äœã§ããïŒ
îKamada Ltdã®ãã£ãã«ãŒã·ã³ãã«ã¯KMDAã§ãã
Kamada Ltdã®52é±é«å€ã¯ãããã§ããïŒ
îKamada Ltdã®52é±é«å€ã¯9.35ã§ãã
Kamada Ltdã®52é±å®å€ã¯ãããã§ããïŒ
îKamada Ltdã®52é±å®å€ã¯6.50ã§ãã
Kamada Ltdã®æ䟡ç·é¡ã¯ãããã§ããïŒ
îKamada Ltdã®æ䟡ç·é¡ã¯400.34Mã§ãã
Kamada Ltd (KMDA) ã®çŸåšã®è©äŸ¡ã¯ãè²·ããããããŒã«ãããã売ããã®ã©ãã§ããïŒ
îã¢ããªã¹ãã«ãããšãKamada LtdïŒKMDAïŒã®ç·åè©äŸ¡ã¯è²·ãã§ãç®æšæ ªäŸ¡ã¯13.00ã§ãã
Kamada Ltd (KMDA) ã®1æ ªåœããå©çïŒEPS TTMïŒã¯ãããã§ããïŒ
îKamada LtdïŒKMDAïŒã®1æ ªåœããå©çïŒEPS TTMïŒã¯0.35ã§ãã